• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Intelligent Care Robot Could Detect COVID-19 Symptoms in Under 10 Seconds

by Fred Pennic 05/22/2020 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Intelligent Care Robot Could Detect COVID-19 Symptoms in Under 10 Seconds

What You Should Know:

– Vayyar and Meditemi partner to create a more intelligent care robot that could detect early-stage COVID-19 symptoms in under 10 seconds.  

– The solution will be used to soften social distancing, restore public confidence in the workplace, and care for people in homes.


Vayyar Imaging an Israeli-based provider of 4D imaging sensor technology and Berlin-based Meditemi (JV of Ogawa and Medisana) a pioneer in robotic healthcare solutions have partnered to develop a more intelligent care robot that provides a range of remote monitoring capabilities, including early detection of COVID-19 symptoms in under 10 seconds, and alerts for health deterioration and falls.

How It Works

The joint solution outfits Meditemi’s health robots with Vayyar’s 4D intelligent RF sensors to provide fast, robust, and reliable screening and monitoring for early-stage COVID-19 symptoms. When a person approaches the robot, standing within 1 meter of it, it performs a quick, touchless scan to analyze their heart rate (BPM), respiratory rate (RPM), waveforms, and temperature.  The robot’s dashboard then displays in real-time with very high levels of accuracy, key vital signs, and the COVID-19 infection risk level.

Key Benefits for Public, Work, and Home

The intelligent care robot will restore public confidence by providing fast, automatic screening in any public space, such as building entrances, factories, public transport, airports, trade shows, and border crossings, with zero staff involvement or sanitation requirements. In addition, it will enable seniors to be monitored in their residences and alert caregivers of emergency situations or health deterioration. 

“Meditemi robot together with Vayyar technology will help doctors and nurses in providing treatment and giving advice to patients without touching or getting close to the patient in order to reduce virus infection risks for medical personnel,” said Rafael Aviram, President & CEO of meditemi.

The intelligent robots can function in any environmental condition, unaffected by line-of-sight, lighting or weather conditions.  They will keep homes safer by detecting pre-emptive signs of health deterioration and alerting for falls, and in the public sector will bring a holistic COVID detection solution that will hasten the return to normalcy and public confidence.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Caregivers, Coronavirus (COVID-19), Heart, risk, sensors, Vital, workplace

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |